True myeloschisis is a rare, severe birth defect in which the spinal cord stays open on the back because the neural tube did not close early in pregnancy. It is usually recognized before birth on ultrasound or at birth, and it most often affects babies. In plain terms, true myeloschisis can cause serious weakness or paralysis of the legs, loss of bladder and bowel control, and other brain or spine problems, although the features can vary. True myeloschisis is lifelong, and treatment focuses on urgent specialist care after birth, surgery to protect the exposed tissue, and ongoing support for movement, skin, bladder, and bowel needs. Early symptoms of related nerve damage may include poor leg movement and reduced feeling below the spinal opening, and survival depends on how severe the defect is and whether other complications are present.
How many people live with True myeloschisis?
True myeloschisis is so rare that global and U.S. estimates for how many people are living with it are not consistently reported by a single authoritative source. In practice, it is usually grouped together with other open spinal birth defects in registries and studies, so a separate worldwide or U.S. count for true myeloschisis is not reliably available.
Overview
True myeloschisisSymptoms
True myeloschisis is present at birth and causes an open spinal defect, often in the lower back. Common features include leg weakness or paralysis, loss of feeling, and bladder or bowel control problems.
Outlook and prognosis
True myeloschisis is a severe spinal condition. Many affected babies need urgent neurosurgical care soon after birth and often have lifelong weakness or paralysis, bladder and bowel problems, and hydrocephalus. Outlook varies with the spinal level and associated brain changes.
Causes and risk factors
True myeloschisis happens when the neural tube does not close very early in pregnancy. Risk rises with low folate, certain anti-seizure medicines, poorly controlled diabetes, obesity, and a family history or genetic tendency toward neural tube defects.
Genetic influences
Genetics can matter in True myeloschisis, but it is usually not caused by one single gene change. Many living with True myeloschisis are affected by a mix of genetic variations and pregnancy-related factors, especially those linked to folate use and early neural tube development.
Diagnosis
True myeloschisis is usually diagnosed from clinical features seen on prenatal ultrasound or after birth during a physical exam. Imaging such as MRI can help confirm the diagnosis of True myeloschisis and check for related spinal or brain changes.
Treatment and drugs
True myeloschisis needs urgent surgery soon after birth to cover the exposed spinal cord and lower infection risk. Ongoing care often includes treatment for hydrocephalus, plus bladder, bowel, skin, and movement support. Teams tailor care to each child’s needs.
Symptoms
Movement and feeling in the lower body can be limited from birth, and bladder or bowel control is often affected. In True myeloschisis, these problems happen because part of the spinal cord is open on the back and not covered by normal skin. For many people with True myeloschisis, the early features of True myeloschisis are obvious at birth, although severity depends on where the spine is involved. Some babies also have related changes in the feet, hips, or brain.
A flat, open area on the back is usually visible at birth, and the spinal tissue is not covered by normal skin. The area is fragile and can leak fluid, so it needs urgent protection and medical care.
Many babies have weakness or paralysis in the legs below the spinal opening. Some can move the hips but not the lower legs or feet, while others have very little leg movement.
Feeling below the affected part of the spine may be reduced or absent. In daily routines, this might show up as less response to touch, pressure, heat, or pain in the legs or feet.
The nerves that control the bladder and bowels are often affected from birth. This can lead to trouble emptying the bladder fully, urine leakage, constipation, or poor bowel control.
How people usually first notice True myeloschisis?
How true myeloschisis is first noticed is usually very early, often during pregnancy when an ultrasound shows an open spinal defect and blood tests may suggest a neural tube problem. At birth, the first signs of true myeloschisis are typically a clearly visible area on the back where the spinal cord is open and flat, with no skin covering it. Doctors often also look for early related problems, such as weakness in the legs, changes in foot movement, or trouble with bladder and bowel control, although these can vary from one baby to another.
Types of True myeloschisis
No distinct types of True myeloschisis are widely recognized.
Can I slow down the onset of symptoms?
No. True myeloschisis is a severe open spinal birth defect that happens very early in pregnancy, so it is present at birth and there is no known lifestyle change or medical treatment that can delay when symptoms start in a baby who has it. For future pregnancies, taking folic acid before conception and in early pregnancy, along with early prenatal care, is well established to lower the risk of some neural tube defects, but that reduces risk rather than preventing every case.
What genetics can tell you about symptoms
In true myeloschisis, genetics can affect overall risk, but they do not usually predict a clear, specific symptom pattern in one baby. Most cases are thought to result from a mix of many small genetic factors and pregnancy-related influences, so genes may play a part in whether the condition develops, while the level and extent of the spinal opening usually have a bigger effect on how severe problems with movement, feeling, bladder or bowel control, and brain development may be present from birth. In short, genetics can help explain susceptibility, but they are not very good at telling exactly which symptoms will appear, how severe they will be, or when they start, because this condition is present before birth.
Causes and risk factors
True myeloschisis develops very early in pregnancy when the tissue that forms the spinal cord does not close as it should. It is usually multifactorial, so inherited genetic susceptibility can combine with low folate levels, especially before conception and in the first weeks of pregnancy. A family history of neural tube defects, diabetes before pregnancy, obesity, certain anti-seizure medicines, and high body temperature from fever or hot tub use in early pregnancy can raise risk factors for true myeloschisis. It’s rarely just one factor—it’s the mix that matters. In many cases, nothing a parent did on purpose caused true myeloschisis, and taking folic acid before and early in pregnancy can lower the risk of some neural tube defects.
What are the most common causes or risk factors?
The exact cause of true myeloschisis is often not known, but it is usually linked to a mix of inherited risk and things that affect how the baby’s spine forms very early in pregnancy, often before someone knows they are pregnant. The strongest risk factors are not getting enough folic acid, having a family history of this kind of open spine birth defect, and inherited gene changes that affect how the body uses folic acid. Other well-known risks include some seizure medicines, diabetes that is not well controlled before pregnancy, obesity, and high fever or heavy heat exposure early in pregnancy.
Environmental and biological risk factors
True myeloschisis begins very early in pregnancy, often before someone knows they are pregnant. Doctors often group risks into internal (biological) and external (environmental). Understanding the main risk factors for true myeloschisis can help guide pre-pregnancy care and early pregnancy planning.
Low folate levels before pregnancy and in the first few weeks afterward are strongly linked with a higher chance of true myeloschisis. Low vitamin B12 or problems absorbing nutrients can add to this risk in some pregnancies.
Pregestational diabetes, especially when blood sugar is high early in pregnancy, raises the chance of true myeloschisis and other neural tube defects. Good glucose control before conception and very early pregnancy can lower that risk.
A high fever or repeated overheating from sources such as hot tubs or saunas in early pregnancy can increase risk. The concern is greatest during the first month, when the spinal cord is forming.
Some anti-seizure medicines, especially valproate, and drugs that interfere with folate can raise the chance of true myeloschisis if taken around conception. People who need these medicines should review options with their doctor before pregnancy if possible.
Genetic risk factors
When a baby is born with true myeloschisis, families often want to know whether genes played a role and if it could happen again. In most cases, true myeloschisis does not come from a single inherited cause; instead, several genes may each add a small amount to risk. Carrying a genetic change doesn’t guarantee the condition will appear. Doctors usually think about genetic risk factors for true myeloschisis in terms of family history, genes involved in early spinal development, and rare chromosome or single-gene conditions.
Family history: Having one child or close relative with a neural tube defect can raise the chance in a future pregnancy. This suggests shared inherited factors, even when no single gene is found.
Multiple genes: For many families, risk comes from several gene changes acting together rather than one clearly faulty gene. This pattern is often called multifactorial inheritance, and it means testing may not show one simple answer.
Folate-use genes: Changes in genes that help the body handle folate, a B vitamin needed very early in development, may slightly increase risk. These variants usually add only part of the risk and do not explain every case.
Neural closure genes: Rare changes in genes that guide closure of the early spinal cord have been linked to severe open spinal defects, including true myeloschisis. These changes are uncommon, and many affected families never receive a specific gene diagnosis.
Chromosome conditions: Rarely, true myeloschisis appears as part of a broader chromosome condition or genetic syndrome. When other birth differences are also present, genetics specialists may suggest testing to look for this.
Lifestyle risk factors
True myeloschisis is present from birth, so lifestyle habits do not cause it. However, how lifestyle affects True myeloschisis can be important for skin protection, mobility, bladder and bowel care, and the risk of infections or other complications over time. The main lifestyle risk factors for True myeloschisis are the day-to-day habits that make complications more likely or, when managed well, help reduce them.
Long periods in one position can raise the risk of pressure sores in areas with reduced sensation. Regular repositioning, careful cushioning, and daily skin checks can help prevent wounds that may become severe or infected.
Inconsistent catheterization routines, low fluid intake, or poor hygiene can increase urinary retention and urinary tract infections. A structured bladder program and good hydration may lower kidney and bladder complications linked to True myeloschisis.
Low fiber intake, poor fluid intake, and irregular toilet routines can worsen constipation and stool leakage. A consistent bowel program can improve comfort, skin health, and day-to-day function.
Too little movement can worsen muscle weakness, joint stiffness, low endurance, and loss of function. Tailored physical therapy and safe activity may help preserve mobility, improve circulation, and support breathing efficiency.
Risk prevention
True myeloschisis is a severe neural tube defect that develops very early in pregnancy, often before someone knows they are pregnant. Because of that, prevention mainly focuses on lowering the chance that the spinal cord and surrounding tissues do not close normally in the first weeks after conception. Prevention is about lowering risk, not eliminating it completely. For families who have had a pregnancy affected by true myeloschisis, planning ahead with a clinician can make a meaningful difference.
Taking folic acid before pregnancy and during early pregnancy is one of the most important ways to lower the risk of true myeloschisis and related spinal birth defects. Most people are advised to start before conception, since the neural tube closes in the first month of pregnancy. If you have had a prior affected pregnancy, your doctor may recommend a higher dose.
Because true myeloschisis begins so early, trying to optimize health before conception matters more than waiting until later prenatal visits. You don’t need to change everything at once—every bit helps. This is especially important for people thinking about pregnancy after a family history of neural tube defects.
Having diabetes before pregnancy can raise the risk of neural tube defects, including true myeloschisis, if blood sugar is not well controlled. Working toward steady glucose levels before conception and in early pregnancy can help lower that risk.
Some anti-seizure medicines, especially valproate, are known to increase the risk of spinal and brain birth defects. People who could become pregnant should review prescriptions with their doctor before conception, rather than stopping medicines on their own. Safer alternatives may be possible for some.
Can you prevent True myeloschisis?
True myeloschisis cannot always be prevented, but the risk of this serious spinal birth defect may be lowered in some pregnancies. The most proven step is getting enough folic acid, a B vitamin, before pregnancy and during the first weeks of pregnancy, because the spine forms very early. It can also help to manage diabetes well and review medicines with a doctor before pregnancy, especially medicines known to affect early fetal development.
Transmission
True myeloschisis is a congenital condition, not an infection, so it cannot be caught from or passed to other people. For many families, the main question is how True myeloschisis is inherited, and the answer is that it usually does not follow a simple parent-to-child pattern.
The genetic transmission of True myeloschisis is thought to involve a mix of inherited susceptibility and non-genetic factors that affect very early development in pregnancy. Most cases happen as isolated events, but if one pregnancy has been affected, the chance is somewhat higher in a future pregnancy, so genetic counseling can help families understand personal risk.
When to test your genes
For true myeloschisis, genetic testing is not usually the main tool for early detection or day-to-day care. Early detection relies more on preconception counseling, maternal blood screening, and prenatal ultrasound; genetic counseling may help if you have a previous pregnancy affected by a neural tube defect or a strong family history.
Diagnosis
True myeloschisis is usually recognized because the spinal cord and nearby tissues do not close normally before birth, creating a characteristic open area along the back. In many cases, the diagnosis of true myeloschisis begins during pregnancy with imaging and is then confirmed after birth with a careful physical exam. Early and accurate diagnosis can help you plan ahead with confidence.
A pregnancy ultrasound often gives the first clear clue by showing an open spinal defect and changes in the baby’s spine. It may also show related findings in the brain that can happen with open neural tube defects.
Doctors may check maternal blood for alpha-fetoprotein, a protein that can be higher than expected when the spinal opening is exposed. In some pregnancies, amniotic fluid testing can add support if the ultrasound findings are uncertain.
After birth, doctors usually diagnose true myeloschisis by examining the back and the exposed tissue directly. The appearance is often distinctive, which helps separate it from other types of spinal opening.
Imaging findings from spinal ultrasound in a newborn or an MRI can help show how much of the spinal cord and nearby structures are involved. This can help confirm the diagnosis and guide treatment planning.
How is True myeloschisis diagnosed?
True myeloschisis is usually found before birth with a pregnancy ultrasound, which can show that the baby’s spine and spinal cord have not closed normally; a blood test during pregnancy may also show a higher level of a marker linked to open spinal problems. If the ultrasound is not clear, doctors may use fetal MRI, a scan that gives a more detailed picture, and after birth the diagnosis is usually confirmed by examining the open area on the back and sometimes doing imaging of the spine and brain. Genetic testing is not usually the main way this condition is diagnosed, but it may be considered if doctors think there could be another inherited condition as well.
Stages of True myeloschisis
True myeloschisis does not have defined progression stages. This is because it is a structural problem of the spine and spinal cord that develops before birth, rather than an illness that gradually moves through set phases over time. Often the process begins when routine pregnancy ultrasound shows signs of an open spinal defect, and doctors may use detailed ultrasound and sometimes fetal MRI to confirm what is present. After birth, the diagnosis is based on the visible opening, a physical exam, and imaging to look for related findings, while ongoing care focuses on the baby’s nerve function, movement, bladder and bowel control, and complications rather than tracking early symptoms of True myeloschisis through stages.
Outlook and prognosis
The outlook for true myeloschisis is generally poor because the exposed, non-neurulated spinal cord is associated with severe and usually permanent neurologic impairment below the level of the lesion. Most affected infants have profound weakness or paralysis of the legs, loss of bladder and bowel control, and a high risk of orthopedic complications, while associated Chiari II malformation and hydrocephalus can further worsen long-term function and require neurosurgical treatment. Survival has improved with modern neonatal intensive care, prompt closure of the spinal defect, and management of complications, but outcomes depend heavily on the level and extent of the lesion and on whether other major anomalies are present. Mortality is highest in the newborn period when there are severe associated malformations, infection, respiratory compromise, or complications of prematurity. Among survivors, lifelong disability is common, and many require multidisciplinary care for mobility, continence, skin protection, and developmental support. Prenatal diagnosis and coordinated perinatal planning can improve short-term safety, but they do not reverse the underlying spinal cord injury.
Long-term effects
For many living with true myeloschisis, the long-term picture depends mostly on how much of the spinal cord and nearby nerves were affected before birth. Many of the lasting effects involve movement, feeling, bladder and bowel control, and the brain and spine, so daily life can range from needing some support to needing full-time care. Long-term effects vary widely, but true myeloschisis is usually linked with more severe lifelong disability than milder forms of spina bifida.
Weakness or paralysis of the legs is common, and the level of spinal involvement often shapes how much independent standing or walking is possible. Over time, many people with true myeloschisis also develop muscle tightness, joint contractures, or uneven posture.
Areas below the spinal defect may have reduced or absent feeling, which can make injuries or pressure sores harder to notice. This may affect comfort, balance, and skin health across childhood and adult life.
Many living with true myeloschisis have lifelong problems with bladder control and bowel function because the nerves that help these organs work are affected. For many, this can mean leakage, constipation, urinary infections, or kidney complications over time.
Some people develop hydrocephalus, which is a buildup of fluid in and around the brain, and this can become a major long-term feature of true myeloschisis. Depending on severity, it may affect learning, vision, headaches, or overall development.
How is it to live with True myeloschisis?
Living with true myeloschisis is often medically intense from the very start, because the spinal cord is exposed at birth and many children develop significant weakness or paralysis, loss of feeling below the affected level, and bowel and bladder problems that require daily care. For many living with this condition, everyday life can include mobility equipment, skin protection, regular therapy, and frequent visits with specialists, and some also have related brain or nerve complications that affect learning, feeding, or overall development. This usually shapes family life too, with parents and other caregivers taking on a large role in hands-on care, appointments, and home adaptations, while emotional, social, and practical support can make a real difference for everyone involved.
Treatment and drugs
True myeloschisis is treated with urgent specialist care, usually starting right after birth to protect the exposed spinal cord, lower the risk of infection, and plan surgery to close the opening if that is possible and appropriate. There is no medicine that cures True myeloschisis itself, so treatment focuses on surgery, careful wound care, pain control, and support for related problems such as weakness, bladder or bowel trouble, and hydrocephalus, which is extra fluid around the brain. Treatment plans often combine several approaches. Many living with True myeloschisis also need long-term follow-up with neurosurgery, rehabilitation, physical therapy, and bladder and bowel specialists to support day-to-day function and comfort. Because the condition can vary in severity, the best treatment for True myeloschisis depends on the spinal findings, overall health, and whether problems are found before birth or after delivery.
Can you cure True myeloschisis?
No, true myeloschisis cannot be cured. It is a severe birth condition in which the spinal cord does not form and close the usual way, and treatment cannot undo the nerve damage that is already there. Care usually focuses on closing and protecting the area as early as possible and helping with problems such as movement, bladder, bowel, and skin care.
Non-drug treatment
Day-to-day care for people living with True myeloschisis often centers on protecting the exposed spinal tissue, preventing complications, and supporting movement, bladder, and bowel function as a child grows. Managing this condition often takes a team that may include neurosurgery, rehabilitation, urology, orthopedics, and nursing specialists. The main treatment for True myeloschisis is usually surgery soon after birth, with ongoing therapies tailored to each child’s needs.
Surgery is usually done very soon after birth to cover and protect the open area of the spine. This lowers the risk of infection and helps prevent further injury to the exposed nerves. In many families, treatment for True myeloschisis in newborns begins with careful delivery planning and prompt transfer to a surgical center.
Before and after surgery, careful skin and wound care help protect the spinal area from drying, pressure, and contamination. Gentle positioning and special dressings can reduce damage to fragile tissue and support healing.
Physical therapy helps children build strength, practice safe movement, and make the most of the muscle function they have. Some may find that early stretching and guided play improve comfort, positioning, and joint flexibility.
Occupational therapy supports day-to-day skills such as feeding, dressing, sitting balance, and hand use as children grow. It can also help families adapt the home and choose equipment that makes daily routines easier.
Your genes may have an impact on how drugs work for you
For people living with true myeloschisis, there is no well-established evidence that inherited gene differences regularly change how the main medicines used in care work, because treatment is centered more on surgery, wound care, infection prevention, and symptom support than on long-term condition-specific drugs. In day-to-day care, doctors usually choose medicines based on things like a baby’s age, body size, kidney function, liver function, and overall health rather than on genetic testing. As research grows, this could change for some medicines, but right now gene-based prescribing is not a routine part of care for true myeloschisis.
Pharmacological treatments
True myeloschisis is usually managed mainly with urgent supportive care and surgery, because no medicine can close the spinal cord opening itself. Medication can feel like a big step, but in true myeloschisis, drugs are mostly used to prevent infection, control pain, and treat related problems such as bladder or bowel dysfunction. The exact plan depends on the baby or child’s symptoms and any complications, so there is no single drug regimen for everyone living with true myeloschisis. Families often ask about the early symptoms of true myeloschisis, but once it is identified, treatment decisions are guided more by the exposed spinal tissue and the baby’s overall stability than by symptoms alone.
Antibiotics such as ampicillin and gentamicin may be used if there is concern about infection around the open spinal area or elsewhere in the body. They do not treat true myeloschisis itself, but they can be important before or after surgery when infection risk is high.
Acetaminophen and, after surgery, stronger pain medicines such as morphine may be used to keep a baby comfortable. The choice depends on age, breathing, feeding, and how much pain is expected.
Some children with true myeloschisis later develop a bladder that does not empty or store urine normally, which is called neurogenic bladder. Drugs such as oxybutynin may help relax the bladder and protect the kidneys, often along with catheter use.
Constipation can become an ongoing issue in children who survive with nerve-related bowel problems from true myeloschisis. Laxatives such as polyethylene glycol or stool softeners may be used to help stools pass more regularly and comfortably.
Genetic influences
When a baby is born with true myeloschisis, many families want to know whether it could happen again. It’s natural to ask whether family history plays a role. True myeloschisis is usually not caused by one single inherited gene; instead, risk seems to come from a mix of small genetic differences and other factors that affect very early spinal development. Genes involved in how the body handles folate may affect this risk, and having relatives with a neural tube defect can make true myeloschisis more likely, but it does not fully predict who will be affected. This is why whether true myeloschisis runs in families is often only part of the story, and many affected pregnancies happen with no known family history. If other birth differences are present, doctors may sometimes look for a broader genetic syndrome or chromosome change, but for most families, genetics influences risk rather than causing true myeloschisis in a simple, clearly inherited pattern.
Is True myeloschisis genetic?
Genetics can matter in True myeloschisis, but it is usually not caused by one single gene change. Many living with True myeloschisis are affected by a mix of genetic variations and pregnancy-related factors, especially those linked to folate use and early neural tube development.
Having a genetic risk is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most of them do not directly affect health; they are simply one aspect of natural human diversity. In many genes, carrying a variant tied to a condition indicates a possible association, not a firm diagnosis, especially when several genes and environmental factors contribute. In some cases, however, a single well-characterized variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For families facing true myeloschisis, treatment is usually guided more by the spinal opening and the baby’s nerve function than by genetic test results. Most care focuses on protecting the exposed tissue, lowering the risk of infection, and planning surgery and long-term support for movement, bladder, and bowel problems, so there is no single drug chosen because of true myeloschisis itself. Not every difference in response is genetic, but some babies have related genetic changes or other birth differences that can shape the overall care plan and may affect how carefully certain medicines are dosed or monitored. Doctors may also use genetic information to estimate the chance of another pregnancy being affected, which matters more for prevention with folic acid before and early in pregnancy than for choosing medicines after birth. So when people ask how genetics influence the treatment of true myeloschisis, the answer is usually that genetics helps explain risk and related health needs, while day-to-day treatment depends mainly on surgery, infection prevention, rehabilitation, and close follow-up with a specialist team.
Interactions with other conditions
For families, the biggest concern is often not just the spinal opening itself, but the other serious health problems that can come with true myeloschisis. This condition is often linked with other problems of the brain and spine, especially hydrocephalus, which is a buildup of fluid in the brain, and Chiari II malformation, where part of the lower brain sits too low. Because the spinal tissue is exposed, babies with true myeloschisis also have a high risk of severe infection, including meningitis, if treatment is not immediate. Many living with related open spinal defects can also have bladder and bowel nerve problems, which may raise the chance of repeated urinary tract infections and, over time, kidney damage. Another important aspect is how it may link with other diseases. Interactions can look very different from person to person, but early specialist care usually focuses on the spinal defect, brain pressure problems, and preventing infection or organ damage.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to True myeloschisis?
Other spinal birth defects can look similar, especially myelomeningocele and meningocele, which are other forms of spina bifida. Doctors may also consider a tethered spinal cord and rare lower-spine conditions such as caudal regression syndrome, because they can also cause leg weakness, changes in feeling, and trouble with bladder or bowel control.
History
For families, true myeloschisis has usually entered the story at birth, often after a pregnancy that seemed normal or after an ultrasound raised concern late in pregnancy. Older medical reports described babies born with a severe opening in the lower back, where the developing spinal cord was exposed rather than covered by skin. Before modern newborn care, this was often difficult to understand and even harder to treat.
As doctors learned more about birth differences affecting the brain and spine, they began separating true myeloschisis from other spinal conditions that can look similar at first glance. This mattered because true myeloschisis is one of the most severe forms of open spinal cord development problems, and it tends to be linked with major nerve damage from the start. In recent decades, awareness has grown, and imaging during pregnancy has made it easier to recognize these problems before birth, helping families and care teams plan delivery and immediate treatment.
The history of true myeloschisis is also tied to wider progress in prenatal vitamins, ultrasound, neonatal intensive care, and surgery. Researchers later identified that these conditions arise very early in fetal development, when the tissues that form the brain and spinal cord do not close as expected. That better understanding did not change how serious true myeloschisis can be, but it did improve prevention of some related neural tube defects and gave doctors clearer ways to explain what they were seeing.
Today, true myeloschisis is still considered rare, and many living with severe open spinal cord conditions need highly specialized care from birth onward. Historical descriptions were not always consistent, and some older case reports likely grouped different conditions together. Even so, that long medical record helped shape what clinicians now know about the early symptoms of true myeloschisis, how it appears on prenatal scans, and why quick, coordinated care is so important.